Zaprinast
Zaprinast (M&B 22948) is a selective inhibitor of cGMP-selective Phosphodiesterase (PDE5) . Zaprinast causes a significant increase in cGMP levels in myocytes. Zaprinast is a G protein-coupled receptor 35 (GPR35) agonist which activates rat GPR35 strongly and activates human GPR35 moderately. Zaprinast reduces vessel remodeling through antiproliferative and proapoptotic effects[1][2][3].
Product Specifications
CAS Number
[37762-06-4]
Product Name Alternative
M&B 22948
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
GPR35 ; Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease; Cardiovascular Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/zaprinast.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1C(N=NN2)=C2N=C(C3=CC=CC=C3OCCC)N1
Molecular Formula
C13H13N5O2
Molecular Weight
271.27
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE5
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items